Restoring Iron Deficiency in POTS

Last updated: December 9, 2025
Sponsor: Vanderbilt University Medical Center
Overall Status: Active - Recruiting

Phase

2

Condition

N/A

Treatment

Intravenous iron

Clinical Study ID

NCT07197905
250671
  • Ages 18-45
  • Female

Study Summary

People with postural orthostatic tachycardia syndrome (POTS) often have low red blood cell volumes and low ferritin in their blood (a marker of iron storage in the body). The purpose of this pilot study is to investigate whether giving iron to people with POTS who have low ferritin levels will increase the red blood cell volume and improve POTS symptoms.

Eligibility Criteria

Inclusion

Inclusion Criteria

  • Age 18-45 years old.

  • Diagnosis of POTS, defined by a sustained heart rate increase of at least 30 bpm within 10 min of standing or head-up tilt (or absolute upright heart rate >120 bpm), in the absence of orthostatic hypotension, and with at least 3 months of symptoms of orthostatic intolerance.

  • Absence of other diseases or medications that can explain orthostatic tachycardia or symptoms.

  • Serum ferritin <50 ng/ml.

  • Patients on fludrocortisone will be allowed to participate as long as they have been on the same dose for at least one month before enrollment and continue on the same dose throughout the study.

Exclusion Criteria

  • Unable or unwilling to provide consent.

  • Pregnancy.

  • Being chair- or bed-ridden.

  • Unable to hold POTS medications during study procedures (i.e., autonomic testing).

  • History of active bleeding (other than menstruation).

  • History of hypersensitivity to any iron preparation of recent (within 6 months) treatment with any IV iron preparation.

Study Design

Total Participants: 12
Treatment Group(s): 1
Primary Treatment: Intravenous iron
Phase: 2
Study Start date:
November 24, 2025
Estimated Completion Date:
December 31, 2026

Study Description

This pilot study involves undergoing a physical exam and medical history, answering some questionnaires, and visiting the Vanderbilt Autonomic Dysfunction Center before and 2 months after the iron treatment for bloodwork, blood volume measurements, autonomic function tests, and wearing an activity monitor.

Connect with a study center

  • Autonomic Dysfunction Center/ Vanderbilt University Medical Center

    Nashville 4644585, Tennessee 4662168 37232
    United States

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.